Prevention of Ornithine Cytotoxicity by Nonpolar Side Chain Amino Acids in Retinal Pigment Epithelial Cells

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 11, 2003, Pages 5023-5028

  Nakauchi, Tadashi ^a   Ando, Akira ^a   Ueda Yamada, Mami ^a   Yamazaki, Yukari ^a   Uyama, Masanobu ^a   Matsumura, Miyo ^a   Ito, Seiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 NORBORNANECARBOXYLIC ACID; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMINO ACID TRANSPORTER; LEUCINE; NORBORNANE DERIVATIVE; ORNITHINE; PROLINE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROTECTION; CHORIORETINOPATHY; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE MODEL; HUMAN; HUMAN CELL; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA GYRATE ATROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME SERIES ANALYSIS;

AMINO ACID TRANSPORT SYSTEM Y+; AMINO ACIDS; AMINO ACIDS, CYCLIC; ANTIGENS, CD98 HEAVY CHAIN; ANTIGENS, CD98 LIGHT CHAINS; CELL SURVIVAL; CELLS, CULTURED; COLORIMETRY; CYTOPROTECTION; GYRATE ATROPHY; HUMANS; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; ORNITHINE; ORNITHINE-OXO-ACID TRANSAMINASE; PIGMENT EPITHELIUM OF EYE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLIUM SALTS; THIAZOLES;

EID: 0142231896     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0403     Document Type: Article

References (21)

1. Valle D, Simell O. The hyperornithinemias. In: Scriver C, Beaudet A, Sly W, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995:1147-1185.
2. Simell O, Takki K. Raised plasma-ornithine and gyrate atrophy of the choroid and retina. Lancet. 1973;1(7811):1031-1033.
3. O'Donnell JJ, Sandman RP, Martin SR. Gyrate atrophy of the retina: inborn error of L-ornithine: 2-oxoacid aminotransferase. Science. 1978;200:200-201.
4. Shih VE, Berson, EL, Mandell R, Schmidt SY. Ornithine ketoacid transaminase deficiency in gyrate atrophy of the choroid and retina. Am J Hum Genet. 1978;30:174-179.
5. Valle D, Kaiser-Kupfer MI, Del Valle LA. Gyrate atrophy of the choroid and retina: deficiency of ornithine aminotransferase in transformed lymphocytes. Proc Natl Acad Sci. 1977;74:5159-5161.
6. Daune G, Gerhart F, Seiler N. 5-Fluoromethlyornithine, an irreversible and specific inhibitor of L-ornithine: 2-oxo-acid aminotransferase. Biochem J. 1988;253:481-488.
7. Ueda M, Masu Y, Ando A, et al. Prevention of ornithine cytotoxicity by proline in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1998;39:820-827.
8. Lodato RF, Smith RJ, Valle D, Phang JM, Aoki TT. Regulation of proline biosynthesis: the inhibition of pyrroline-5-carboxylate synthase activity by ornithine. Metabolism. 1981;30:908-913.
9. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349-352.
10. Boulanger A, Redmond TM. Expression and promoter activation of the Rpe65 gene in retinal pigment epithelium cell lines. Curr Eye Res. 2002;24:368-375.
11. Rambhatla L, Chiu CP, Glickman RD, Rowe-Rendleman C. In vitro differentiation capacity of telomerase immortalized human RPE cells. Invest Ophthalmol Vis Sci. 2002;43:1622-1630.
12. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
13. Matthews RH, Sardovia M, Lewis NJ, Zand R. Biphasic kinetic plots and specific analogs distinguishing and describing amino acid transport sites in S37 ascites tumor cells. Biochim Biophys Acta. 1975;394:182-192.
14. Pineda M, Ferandez E, Torrents D, et al. Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem. 1999;274:19738-19744.
15. +L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family. EMBO J. 1999;18:49-57.
16. Yoo J-S, Sakamoto T, Spee C, et al. cis-Hydroxyproline inhibits proliferation, collagen synthesis, attachment, and migration of cultured bovine-retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1997;38:520-528.
17. Ando A, Ueda M, Uyama M, Masu Y, Okumura T, Ito S. Heterogeneity in ornithine cytotoxicity of bovine retinal pigment epithelial cells in primary culture. Exp Eye Res. 2000;70:89-96.
18. Wang T, Steel G, Milam AH, Valle D. Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina. Proc Natl Acad Sci USA. 2000;97:1224-1229.
19. Boado RJ, Li JY, Nagata M, Zhang C, Pardridge WM. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci USA. 1999;96:12079-12084.
20. Kido Y, Tamai I, Uchino H, Suzuki F, Sai Y, Tsuji A. Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier. J Pharm Pharmacol. 2001;53:497-503.
21. Matsuo H, Tsukada S, Nakata T, et al. Expression of a system L neutral amino acid transporter at the blood-brain barrier. Neuroreport. 2000;11:3507-3511.